SCHEMBL3508633

SCHEMBL3508633

O=C(O)Cc1ccc(Oc2ccccc2OC/C=C/c2ccc(C(F)(F)F)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 4/20 0.50
ALOX5 P09917 2/20 0.50
PSEN1 P49768 2/20 0.50
PTGES O14684 1/20 0.50
THRB P10828 2/20 0.46
LTA4H P09960 1/20 0.45
EPHX2 P34913 1/20 0.45
S1PR5 Q9H228 3/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
RXRA P19793 1/20 0.43
RXRB P28702 1/20 0.43
RXRG P48443 1/20 0.43
MAPK14 Q16539 1/20 0.42
PPARA Q07869 3/20 0.41
PPARD Q03181 2/20 0.41
SRD5A2 P31213 1/20 0.41
FFAR1 O14842 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
THRA P10827 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3508636 1.00 PPARG (0.50) PPARGALOX5PSEN1PTGESTHRB
SCHEMBL3506401 0.89 PPARG (0.46) PPARGALOX5PSEN1PTGESTHRB
SCHEMBL3506407 0.89 PPARG (0.46) PPARGALOX5PSEN1PTGESTHRB
SCHEMBL3511527 0.88 PPARA (0.49) PPARGALOX5PSEN1PTGESTHRB
SCHEMBL3511529 0.88 PPARA (0.49) PPARGALOX5PSEN1PTGESTHRB
SCHEMBL3507505 0.87 PPARG (0.47) PPARGALOX5PSEN1PTGESTHRB
SCHEMBL3507500 0.87 PPARG (0.47) PPARGALOX5PSEN1PTGESTHRB
SCHEMBL3510701 0.87 S1PR5 (0.46) PPARGALOX5PSEN1PTGESS1PR5
SCHEMBL3510699 0.87 S1PR5 (0.46) PPARGALOX5PSEN1PTGESS1PR5
SCHEMBL3510250 0.86 PPARG (0.46) PPARGALOX5PSEN1PTGESTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100267778-A1 Diphenyl ether compound, process for producing the same, and use ONO PHARMACEUTICAL CO., LTD. (JP) 2010-10-21 US disclosed
EP-1661879-A1 DIPHENYL ETHER COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE ONO PHARMACEUTICAL CO., LTD. (JP) 2006-05-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267778-A1 Diphenyl ether compound, process for producing the same, and use PPARG, PPARD, PPARA PPARG 1/4885ALOX5 884/4885PSEN1 3599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.